Hyperbilirubinemia may lead to neurotoxicity and neuronal death. Although the mechanisms of nerve cell damage by unconjugated bilirubin (UCB) appear to involve a disruption of the redox status and excitotoxicity, the contribution of nitric oxide (
INTRODUCTION
Oxidative stress occurs when the production of reactive oxygen and/or nitrogen species overwhelms the antioxidant defence capacity (1) . Among the reactive nitrogen species there is nitric oxide (
. NO), a free radical formed by a group of constitutive and inducible nitric oxide synthase (NOS) enzymes (2 citrulline from L-arginine and oxygen (3, 4) .
Once produced, . NO can importune numerous biological events by reacting with various metals, thiols, and oxygen species, modifying proteins, DNA and lipids.
One of the most biologically relevant actions of . NO is its binding to the heme moiety in the heterodimeric enzyme, soluble guanylate cyclase (sGC). Activation of sGC by primary cortical cultures and in a variety of model systems (8) (9) (10) . At the subcellular level, . NO leads to mitochondrial dysfunction and consequent energy deficiency that may constitute a driving pathway to neurodegeneration (11) .
Unconjugated bilirubin (UCB) is an endogenous compound that at low concentrations can be beneficial due to its antioxidant properties, whereas at higher levels can induce cytotoxicity, particularly to the central nervous system (12) . Toxic effects by UCB include the disruption of cell membrane structure and dynamic properties (13) (14) (15) , as well as alterations in membrane potential, transport and enzymatic systems (16) (17) (18) (19) . The extracellular accumulation of glutamate, due to impaired uptake and/or enhanced secretion (20-23) indicates that UCB prolongs the presence of glutamate in the synaptic cleft. Moreover, the activation of NMDA receptors found in developing rat brain neurons exposed to UCB (24,25), together with the association between jaundice and damage in Gunn rats (26) , point to excitotoxicity as a key player in UCB neurotoxicity.
We have been compiling evidence that oxidative stress is involved in the mechanisms of UCB cytotoxicity. In fact, blood samples from moderately jaundiced neonates present higher levels of membrane-bound hemoglobin (12, 27) , an indicator of oxidative stress (28) . Studies by spin-labeling electron paramagnetic resonance spectroscopy analysis indicated that UCB disrupts the redox status of isolated mitochondria (14) , intact nerve cells (15) , and dipalmitoyl phosphatidylcholine liposomes (unpublished observations). Moreover, injury to neocortical synaptosomes was linked to a disruption of the redox status (18), also observed in primary cultures of neurons (29, 30) . More recently, we demonstrated that deregulation of energy metabolism is also involved in UCB-induced oxidative injury to immature neurons (31) . However, the contribution of . NO as well as of NMDA receptors in the neuronal 
MATERIALS AND METHODS

Chemicals
Neurobasal medium, B-27 Supplement (50×), Hanks' balanced salt solution (HBSS-1), Hanks' balanced salt solution without Ca 2+ and Mg 2+ (HBSS-2), gentamicin (50 mg/mL), trypsin (0.025%) were purchased from Invitrogen (Carlsbad, CA, USA).
Fetal calf serum (FCS) was obtained from Biochrom AG (Berlin, Germany). Neuronal cell cultures were prepared from the cerebrum cortical region of Wistar rats, and neurons were isolated from fetuses of 17-18-day pregnant rats, as previously described (21). Cells were morphologically characterized by phasecontrast microscopy and used after 8 days in vitro. Our cell culture protocol greatly avoids contamination by glial cells (33) , which was lower than 1% as assessed by immunocytochemical staining using primary antibodies raised against glial fibrillary acidic protein of astrocytes. Incubation conditions with UCB were selected based on our previous studies (29, 34) , where we used the UCB concentrations of 50 and 100 µM in the presence of HSA, thus corresponding to UCB/HSA molar ratios of 0.5 and 1.0, respectively. The later concentration showed to repeatedly induce more consistent results when working with neurons (34) . Thus, in the present study we used the UCB/HSA molar ratio of 1.0 to assess whether the effects produced by UCB could be prevented, what we expect to be more evidently shown in this condition. To mention that higher UCB concentrations and UCB/HSA molar ratios have been avoided by us due to the lack of pathophysiologic meaning. A 4 h incubation was selected based on our previous studies (12) showing that although producing a statistically significant increase in LDH release, excessive extent of cell death by UCB is avoided, which would compromise the assessment of functional indicators as nNOS. Therefore, neurons were treated with 100 µM UCB, 100 µM L-NAME, UCB plus L-NAME, or no addition (control), in the presence of 100 µM HSA, for 4 h at 37ºC. 
Quantification of nitrite levels
Measurement of Cyclic guanosine 3',5'-monophosphate concentrations
The synthesis of . NO can be determined either by measuring its breakdown product, nitrite, or by measuring its ability to stimulate sGC, leading to cGMP production (4). For quantification of cGMP content, the phosphodiesterase inhibitor 1-isobutyl-3-methylxanthine was included in the incubation medium. Cell extracts collected from 9.6 cm 2 wells were used for cGMP determination using the commercially available kit from Enzo Life Sciences, and measurements were performed according to manufacturer's instructions.
Assessment of protein oxidation
Protein-resident carbonyls were measured as a marker of oxidative stress by slot blot analysis of the 2,4-dinitrophenylhydrazone (DNP-hydrazone) adducts of the carbonyls formed by reaction with 2,4-dinitrophenylhydrazine (DNPH). At the end of incubation, cells were rinsed with ice-cold PBS, harvested by scraping into PBS, the cell suspension was sonicated and carbonyls formation was quantified using the OxyBlot kit, as previously described (29, 30) .
Glutathione determination
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GSH levels were calculated from those of total glutathione (GSt) and GSSG
[GSt = GSH plus two times GSSG]. GSt was determined by an enzymatic recycling procedure and GSSG was determined following derivatization of GSH by reaction with 2-vinylpyridine, as previously described (29) .
Assessment of cell function
Cellular reduction of MTT was measured in neurons as previously described by us (21). Briefly, after the incubation period, neurons were incubated for 1 h, at 37°C, with 500 μL of MTT at 0.5 mg/mL, prepared by dilution of a freshly prepared stock solution at 5 mg/mL in Neurobasal medium. After incubation, medium was discarded and MTT formazan crystals were dissolved by addition of 1 mL isopropanol/HCl 0.04 M and gentle shaking for 15 min, at room temperature. After centrifugation, absorbance values at 570 nm were determined in a Unicam UV2 spectrophotometer (Unicam Limited, UV2, Cambridge, UK). Results were expressed as percentage of control, which was considered as 100%.
Cytotoxicity evaluation
We measured LDH release by cells with a disrupted membrane as a tool to ascertain the extent of cell death. LDH activity was quantified in the incubation medium using the Cytotoxicity Detection Kit, LDH, as previously described (29, 30) .
The results were expressed as percentage of total LDH release, obtained by lysing non-incubated cells with 2% Triton X-100 in Neurobasal medium for 30 min. 
Statistical analysis
RESULTS
UCB enhances nNOS expression in neurons
We started by investigating whether UCB upregulates nNOS in primary cultures of rat neurons by assessing the enzyme expression by Western blot (Fig. 1) .
Incubation of neurons with UCB increased nNOS protein expression by 2-fold (P<0.01). Because L-NAME is known to inhibit NOS activity in an enantiomerically specific manner (4), we evaluated if it was able to prevent the enzyme stimulation by UCB. In fact, when 100 µM L-NAME was associated to UCB the values returned to levels similar to those observed in controls (1.1-fold, N.S.), indicating that UCBinduced increased expression of nNOS was blocked by approximately 90% (P<0.01).
These data demonstrate that UCB at pathophysiologically relevant concentrations induces the expression of nNOS.
UCB promotes nitrite production by neurons
We further evaluated nitrite production, an index of . NO formation, following exposure to UCB. As shown in Figure 2 , UCB induced a 2.4-fold (P<0.01) increase in nitrite levels, whereas co-treatment of neurons with L-NAME significantly reversed UCB-induced effect by 75% (P<0.01). Therefore, UCB induces the production of 
UCB leads to increased cGMP production by neurons
To confirm the augmented synthesis of . NO in UCB-exposed neurons, we determined cGMP, the resulting product of sGC stimulation by . NO (4). As represented in Figure 3 , cGMP levels raised from 13.5 ± 1.5 in controls to 22.6 ± 1.9
pmol/mg protein in UCB-treated samples (P<0.01), and returned to nearly basal values (15.3 ± 2.1) by treatment with UCB in the presence of L-NAME (P<0.05 from UCB alone). These results therefore sustain our hypothesis that . NO production occurs during neuronal exposure to UCB.
. NO is involved in protein oxidation induced by UCB
To clarify whether oxidation of cell components occurs in the conditions used in the present study, measurement of protein carbonyls was selected as a tool to assess the extent of protein oxidation. UCB caused a 24% (P<0.01) increase in the formation of protein carbonyls (Fig. 4) 
NO is involved in the disruption of glutathione homeostasis induced by UCB
Having established that UCB promotes oxidative injury to neuronal proteins, it appeared relevant to look for alterations in the cellular antioxidant defence mechanisms following exposure to UCB. So, we evaluated the intracellular levels of GSH, a low molecular weight thiol with important functions as antioxidant (36) .
Treatment of nerve cells with UCB caused a nearly 20% decrease in GSH levels, from ~13 nmol/mg protein in control assays to ~10 nmol/mg protein in UCB-treated samples (P<0.05) (Fig. 5) . The levels of GSH in control assays accounted for 93% of GSt, which also decreased by approximately 20% following incubation with UCB (13.9 ± 0.8 vs 11.6 ± 0.9 nmol/mg protein, P<0.05). These results show that UCB leads to consumption of antioxidant defences and that disruption of glutathione homeostasis takes place upon neuronal exposure to UCB.
To ascertain whether . NO is involved in the depletion of cellular GSH, sister experiments were performed in the presence of L-NAME. In the presence of the nNOS inhibitor, the disruption of glutathione homeostasis induced by UCB was abrogated, as indicated by the GSH levels of 12.7 ± 0.6 nmol/mg protein (P<0.05 from UCB alone), which were very close to those observed either with L-NAME alone or in control experiments (Fig. 5) . These results, showing that L-NAME prevents the consumption of GSH stores by UCB, reinforce the concept that . NO plays a role in the oxidative disruption of neuronal cells resulting from UCB interaction.
. NO is engaged in UCB-induced neuronal dysfunction Molecular Medicine www.molmed.org
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To assess the effect of UCB on neuronal function, we performed the MTT test after the incubation period. Cell dysfunction in UCB-treated neurons was remarkable (Fig. 6) , as indicated by the higher than 50% decrease in the ability to reduce MTT (P<0.01). Incubation with UCB and L-NAME partially abrogated cell dysfunction, as indicated by the raise in MTT reduction levels, from ~47% in UCB-treated samples to ~72% in those exposed to UCB in the presence of the nNOS inhibitor (P<0.01). By
showing that abolishment of . NO production improves MTT metabolism, these results further point to the involvement of this reactive species in neuronal impairment by UCB.
.
NO is implicated in neuronal death induced by UCB
To evaluate whether .
NO is involved in UCB-induced neurotoxicity, we measured the release of LDH by cells with a disrupted membrane, a characteristic attribute of necrosis/oncosis. We obtained a 1.8-fold (P<0.01) increase in LDH release by neurons exposed to UCB (Fig. 7) . However, the overall cell death did not surpass 10%, assuring that our conditions were desirable to evaluate both the role of nNOS and . NO, in UCB-induced oxidative demise. Therefore, we next evaluated cell death after incubation with a combination of UCB and L-NAME. Interestingly, UCBinduced cell death was almost counteracted by the NOS inhibitor (P<0.05) with values very closely resembling those obtained with L-NAME alone and in controls.
These results strengthen the role of . NO as an intervening molecule in the mechanisms of cell injury by UCB. Additionally, a further corroboration was obtained by the near 80% protection achieved following neuronal incubation with hemoglobin ( Fig. 7) , a NO is implicated in neuronal injury by UCB.
Overstimulation of NMDA receptors mediates UCB-induced activation of nNOS and neurotoxicity
Having established that . NO intervenes in UCB-induced neuronal injury, we wondered whether the disruption of the redox status was a primary event or was secondary to the UCB-induced extracellular accumulation of glutamate (21,22). Thus, we investigated whether the presence of MK-801, a NMDA glutamate-subtype receptor antagonist, was able to prevent the activation of nNOS and cytotoxicity.
Levels of glutamate in the extracellular medium were also determined after treatment with UCB and MK-801, alone or in combination. As indicated in Table 1 
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The present study demonstrates that exposure of neurons to clinically relevant concentrations of UCB leads to activation of nNOS, as well as to production of nitrites and cGMP, which are accompanied by protein oxidation and cell demise, whereas the major cellular antioxidant defence system, provided by GSH, is impaired.
Additionally, it is shown that UCB-induced neuronal oxidative injury is prevented by . NO synthesis inhibition or sequestration, as well as by blockade of NMDA receptor channels with MK-801. These findings point to . NO as a key mediator of UCBinduced oxidative disruption of neuronal cells and that activation of nNOS and neurotoxicity occur through the engagement of NMDA receptors, suggesting that oxidative damage is secondary to overstimulation of the glutamate receptors by UCB.
The imbalance between formation of oxidant species and consumption of the antioxidant defences may be evaluated by oxidative stress biomarkers such as protein carbonyls, a reliable indicator of protein oxidation, and GSH, reflecting the chainbreaking thiol antioxidant capacity of the cell (36, 37) . By showing that exposure of neurons to UCB leads to protein oxidation, as well as to impairment of the antioxidant defences and cell viability, this study provides a causal relationship between UCBinduced oxidative stress and neuronal damage. This assumption is not without precedent since UCB-induced oxidative injury was shown to mediate cell death (15, 29, 30) and a strong correlation between experimental obstructive jaundice and oxidative stress was found in rat brain (38) . Supplementation with the glutathione precursor, N-acetylcysteine, was shown to reverse the obstructive jaundice-induced oxidative stress in rats (38) , as well as the oxidative injury resulting from exposure of rat neurons (30) and HeLa cells (39) to UCB, further reinforcing the redox disruption as a cause of nerve cell impairment. These facts support our observation of a decrease in GSH and GSt levels by UCB that indicate the consumption of the tripeptide, is abrogated by N-ω-nitro-L-arginine methyl ester (L-NAME). Primary cultures of rat neurons were treated for 4 h at 37ºC with either 100 µM UCB, 100 µM L-NAME, UCB plus L-NAME, or no addition (control), in the presence of 100 µM human serum albumin (HSA). The formation of nitric oxide was indirectly evaluated by measuring nitrites in the incubation medium using the Griess reagent, as described in Materials and methods. ** P<0.01 from control; $$ P<0.01 from UCB alone. 
at 37ºC with either 100 µM UCB, 100 µM L-NAME, UCB plus L-NAME, or no addition (control), in the presence of 100 µM human serum albumin (HSA).
Formation of cGMP was assessed using a commercial kit, as described in Materials and methods. **P<0.01 from control; $ P<0.05 from UCB alone. which is restored by N-ω-nitro-L-arginine methyl ester (L-NAME). Primary cultures of rat neurons were treated for 4 h at 37ºC with either 100 µM UCB, 100 µM L-NAME, UCB plus L-NAME, or no addition (control), in the presence of 100 µM human serum albumin (HSA). Intracellular levels of reduced glutathione (GSH) were determined by an enzymatic recycling procedure, as described in Materials and methods. * P<0.05 from control; $ P<0.05 from UCB alone. neurons were treated for 4 h at 37ºC with either 100 µM UCB, 100 µM L-NAME, UCB plus L-NAME, or no addition (control), in the presence of 100 µM human serum 
